Dr. Lal PathLabs has informed that pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Nomination & Remuneration Committee (Committee) on Thursday, July 29 2021 granted 750 Restricted Stock Unit options (Options) under the Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2016 (RSU 2016/ Plan).
The above information is a part of company’s filings submitted to BSE.